AMY SHAW: Open Payments
NPI 1881449908 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 29 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $414 |
| Axsome Therapeutics, Inc. | 4 | $167 |
| Corium, LLC | 2 | $143 |
| Neurocrine BioSciences, Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: VRAYLAR, Auvelity, Azstarys, INGREZZA, CAPLYTA, SPRAVATO, Jornay PM, ARISTADA.
Industry payments across KY — which companies pay providers there.
